Acceleron Pharma earned strong acclaim as an exceptional, science-driven biopharmaceutical employer centered on groundbreaking rare disease and oncology research before being acquired by Merck. Employee reviews consistently highlighted a collaborative, highly intelligent corporate culture, robust scientific talent, and competitive compensation packages including equity grants. Workplace experiences centered heavily on empowering clinical researchers to advance innovative therapeutics through complex clinical pipelines.